Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone palmitate injection vs Limethasone in rheumatoid arthritis
CTR20131261Phase 2Active
- Sponsor
- Hainan Haochuang Pharmaceutical
- Start
- Jun 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dexamethasone in rheumatoid arthritis (RA) (2 arms), sponsored by Hainan Haochuang Pharmaceutical. Primary endpoints: Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Started Jun 2014; status: active.
02
Drugs
dexamethasone
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20131261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131261.